Clinical Trial Update: Intra-lesional Tumor Boost for Bulky Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intralesional tumor boost therapy for bulky cervical cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Cervical Cancer, Squamous Cell Carcinoma of Cervix | Phase 2 | Status: RECRUITING